As far as we can tell, the biggest beneficiary of the latter is Morris Goldfarb, chair and chief executive of fashion group G-III, which owns brands such as Donna Karan and Converse. Goldfarb was paid ...

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

What Happened: Soriot made a significant move by purchasing 1,677 shares of Agilent Technologies as reported in a Form 4 filing with the U.S. Securities and Exchange Commission. The transaction's ...

Geoffrey Porges, a longtime biotech analyst and well-known Wall Street figure, stepped down as CFO of the New York biotech ...

Delivering the main report Ajitha, a senior nurse in Dorset, England began by condemning the anti-immigrant measures ...

CompQsoft Digital, a global Microsoft solutions and services provider, today announced the appointment of Greg Moser as President and Board Member. Moser joins the leadership team, bringing over 30 ...

AutoFull announces its partnership with Nikola "NiKo" Kova?, one of the world's most celebrated CS2 professionals. As ...

Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder ...

(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks. The FTSE 100 index closed up 0.59% at 8,684.44 points, while the FTSE 250 ...

in Sweden; and as part of a $500 million investment in a new facility in England. AstraZeneca has been under the direction of Pascal Soriot, who was named its CEO a year ago. Soriot has stepped up the ...

Stock markets tumbled on the steeper-than-expected drop as the scale of the slump sent investors into a fresh flight from US assets, while economists warned the drop in output shows the rising risk of ...